-
1.
公开(公告)号:US11730378B2
公开(公告)日:2023-08-22
申请号:US17229898
申请日:2021-04-14
申请人: Pacesetter, Inc.
发明人: Stephanie C. Sun , Xiaoyi Min , Alan B. Vogel , Fujian Qu , Stuart Rosenberg
IPC分类号: A61B5/0205 , A61B5/00 , A61B7/02 , A61B7/04 , A61B5/283 , A61B5/024 , A61B5/08 , A61B5/11 , A61B5/0245
CPC分类号: A61B5/0205 , A61B5/283 , A61B5/686 , A61B5/6861 , A61B5/7278 , A61B5/7282 , A61B7/023 , A61B7/04 , A61B5/0245 , A61B5/02438 , A61B5/0803 , A61B5/1116 , A61B5/1118 , A61B5/725 , A61B2562/0209 , A61B2562/162
摘要: Computer implemented methods, systems and devices are provided to monitor for potential heart failure (HF). Cardiac activity (CA) data is obtained and filtered to obtain respiration data indicative of a respiration pattern. The respiration data is analyzed to determine one or more respiration characteristics of interest (COI) that are recorded along with collection time information to form an HF monitoring log. Additionally or alternatively, the CA data is analyzed to detect an event of interest. The cardiac activity data is filtered to obtain respiration data indicative of a respiration pattern, and the respiration data is analyzed for respiration induced under detection of the event of interest from the CA data.
-
公开(公告)号:US11420069B2
公开(公告)日:2022-08-23
申请号:US16799510
申请日:2020-02-24
申请人: Pacesetter, Inc.
发明人: Xing Pei , Brad Lindevig , Stuart Rosenberg , Nima Badie
IPC分类号: A61N1/37 , A61N1/39 , A61N1/05 , A61N1/365 , G01R33/00 , A61B5/055 , G01R33/28 , G01R33/07 , G01R33/09 , A61N1/08
摘要: Embodiments describe herein generally pertain to implantable medical device (IMDs), and methods for use therewith, that can be used to automatically switch an IMD from its normal operational mode to an MRI safe mode, and vice versa, within increased specificity. In certain embodiments, a controller of the IMD uses a magnetic field sensor to determine whether a first magnetic field condition is detected, and uses an accelerometer to determine whether a positional condition is detected. In response to the first magnetic field condition being detected, and the positional condition being detected, the controller can use the magnetic field sensor to determine whether a second magnetic field condition is detected, which differs from the first magnetic field condition. The controller can then cause the IMD to enter the MRI safe mode based at least in part on the first and second magnetic field conditions and the positional condition being detected.
-
公开(公告)号:US11129993B2
公开(公告)日:2021-09-28
申请号:US16100009
申请日:2018-08-09
申请人: PACESETTER, INC.
发明人: Xiaoyi Min , Kyungmoo Ryu , Thanh Tieu , Gene A. Bornzin , Stuart Rosenberg
摘要: A computer implemented method and system for detecting arrhythmias in cardiac activity are provided. The method is under control of one or more processors configured with specific executable instructions. The method obtains cardiac activity (CA) signals at the electrodes of an implantable medical device (IMD) in connection multiple cardiac beats and with different IMD orientations relative to gravitational force. The method obtains acceleration signatures at a sensor of the IMD that are indicative of heart sounds generated during the cardiac beats. The method obtains device location information at the IMD, with respect to the gravitational force during the cardiac beats. The method groups the acceleration signatures associated with the first and second set of cardiac beats into the corresponding one of first and second posture bins based on the device location information. The method identifies a difference between the acceleration signals in the first posture bin in connection with treating a heart condition.
-
公开(公告)号:US10925508B2
公开(公告)日:2021-02-23
申请号:US16194123
申请日:2018-11-16
申请人: PACESETTER, INC.
发明人: Elnaz Lashgari , Stuart Rosenberg , Fujian Qu
IPC分类号: A61B5/04 , A61B5/046 , A61N1/362 , A61N1/37 , A61B5/0464 , A61B5/0468 , A61B5/0456 , A61B5/0472 , A61N1/39 , A61B5/00
摘要: A computer implemented method and system for declaring arrhythmias in cardiac activity are provided. The method and system are under control of one or more processors that are configured with specific executable instructions. The method and system obtain far field cardiac activity (CA) signals for a series of beats and builds an N-dimensional data set from data values for features of interest from the CA signals. The method and system utilize a manifold structure to map the N-dimensional data set, through nonlinear dimensional reduction, onto an M-dimensional data set and declares an atrial fibrillation (AFL) episode based on a relation between the M-dimensional data set and one or more AFL classification criteria.
-
公开(公告)号:US10850107B2
公开(公告)日:2020-12-01
申请号:US16181234
申请日:2018-11-05
申请人: PACESETTER, INC.
发明人: Wenwen Li , Gene A. Bornzin , Nima Badie , Stuart Rosenberg , Luke C. McSpadden , Kyungmoo Ryu
摘要: Systems and methods of performing cardio resynchronization therapy (CRT) on a patient heart include the use of a stimulation system having at least one processor, at least one memory, a pulse generator, a stimulating electrode disposed in proximity to a His bundle of the patient heart, and a sensing electrode adapted to sense electrical activity of the left ventricle (LV) of the patient heart. CRT is provided by applying, using the pulse generator and through the stimulating electrode, a His bundle pacing (HBP) impulse having a first impulse energy. The sensing electrode is then used to measure an LV activation time in response to the HBP impulse. At least one setting of the pulse generator is modified based on the LV activation time such that a subsequent HBP impulse may be provided by the pulse generator via the stimulating electrode using a modified impulse energy.
-
公开(公告)号:US10765860B2
公开(公告)日:2020-09-08
申请号:US15973195
申请日:2018-05-07
申请人: PACESETTER, INC.
发明人: Xiaoyi Min , Kyungmoo Ryu , Keith Victorine , Stuart Rosenberg , Gene A. Bornzin
摘要: A subcutaneous implantable medical device and method (SIMD) provided. A pulse generator (PG) is configured to be positioned subcutaneously within a lateral region of a chest of a patient. The PG has a housing that includes a PG electrode. The PG has an electronics module. An elongated lead is electrically coupled to the pulse generator. The elongated lead includes a first electrode that is configured to be positioned along a first parasternal region proximate a sternum of the patient and a second electrode that is configured to be positioned at an anterior region of the patient. The first and second electrodes are coupled to be electrically common with one another. The electronics module is configured to provide electrical shocks for antiarrhythmic therapy along at least one shocking vector between the PG electrode and the first and second electrodes.
-
公开(公告)号:US10758730B2
公开(公告)日:2020-09-01
申请号:US15672178
申请日:2017-08-08
申请人: PACESETTER, INC.
发明人: Xiaoyi Min , Kyungmoo Ryu , Stuart Rosenberg , David Muller
摘要: Methods, devices and program products are provided for controlling a left univentricular (LUV) pacing therapy using an implantable medical device. Electrodes are configured to be located proximate to an atrial (A) site, left ventricular (LV) site and right ventricular (RV) site of the heart. A conduction different Δ is determined based on i) an atrial-ventricular conduction delay (ARRV) between the A site and the RV site, and ii) an atrial-ventricular conduction delay (ARLV) between the A site and the LV site. A correction term ε is based on intrinsic inter-ventricular conduction delay (IVCD) between the LV and RV. An LV atrial-ventricular pacing (AVLV) delay is set based on the conduction difference Δ, a pacing latency PL and the correction term ε and manages the LUV pacing therapy based on the AVLV delay, wherein the LUV pacing therapy lacks pacing in the RV.
-
公开(公告)号:US20190336747A1
公开(公告)日:2019-11-07
申请号:US15973249
申请日:2018-05-07
申请人: PACESETTER, INC.
发明人: Avi Fischer , Xiaoyi Min , Kyungmoo Ryu , Gene A. Bornzin , Keith Victorine , Stuart Rosenberg , Shubha Asopa
摘要: Methods and devices include making an incision at a single site of a patient. The single site located at an anterior of a chest or abdomen. The method also includes inserting a tunneling tool through the incision at the single site and preparing a first tunnel to a subcutaneous posterior location. A path of the first tunnel at least one of i) extends over a plurality of Intercostal gaps of the chest or ii) extends along and within one of the intercostal gaps. The method also includes positioning a first lead having an electrode within the first tunnel and preparing a second tunnel to a subcutaneous parasternal location along the chest. The method also includes positioning a second lead having an electrode within the second tunnel and positioning a pulse generator within a subcutaneous pocket and operatively coupling the first and second leads to the pulse generator.
-
公开(公告)号:US20190336026A1
公开(公告)日:2019-11-07
申请号:US15973351
申请日:2018-05-07
申请人: PACESETTER, INC.
发明人: Fady Dawoud , Fujian Qu , Stuart Rosenberg , Gene A. Bornzin , Jong Gill , Neha Malhotra , Xiaoyi Min
IPC分类号: A61B5/04 , A61B5/046 , A61B5/0456 , A61B5/0464 , A61B5/042 , A61B5/00 , A61B5/0472
摘要: Computer implemented methods and systems for detecting arrhythmias in cardiac activity are provided. The method is under control of one or more processors configured with specific executable instructions. The method obtains a far field cardiac activity (CA) data set that includes far field CA signals for beats. The method applies a feature enhancement function to the CA signals to form an enhanced feature in the CA data set. The method calculates an adaptive sensitivity level and sensitivity limit based on the enhanced feature from one or more beats within the CA data set and automatically iteratively analyzes a beat segment of interest by comparing the beat segment of interest to the current sensitivity level to determine whether one or more R-waves are present within the beat segment of interest. The method repeats the iterative analyzing operation while progressively adjusting the current sensitivity level until i) the one or more R-waves are detected in the beat segment of interest and/or ii) the current sensitivity level reaches the sensitivity limit. The method detects an arrhythmia within the beat segment of interest based on a presence or absence of the one or more R-waves and records results of the detecting of the arrhythmia.
-
10.
公开(公告)号:US20190336025A1
公开(公告)日:2019-11-07
申请号:US15973126
申请日:2018-05-07
申请人: PACESETTER, INC.
发明人: Fujian Qu , Jong Gill , Neha Malhotra , Stuart Rosenberg , Gene A. Bornzin , Fady Dawoud
IPC分类号: A61B5/04 , A61B5/046 , A61B5/0456 , A61B5/042
摘要: A computer implemented method and system for confirming a device documented arrhythmia in cardiac activity are provided. The method is under control of one or more processors configured with executable instructions. The method obtains a cardiac activity (CA) data set that includes CA signals for a series of cardiac events and includes device documented (DD) markers within the series of cardiac events. The device documented markers are indicative of atrial fibrillation (AF) detected by the ICM utilizing an on-board R-R interval irregularity (ORI) process to analyze the CA signals. The method applies a feature enhancement function to the CA signals to form modified CA signals with enhanced sinus features and analyzes the enhanced sinus features in the modified CA signals. The method utilized a confirmatory feature detection process to identify false AF detection by the ORI process. The method records a result of the analysis identifying false AF detection by the ORI process.
-
-
-
-
-
-
-
-
-